Chen Xia^1*, Yajun Li, MD^2*, Zhongyi Sun^3*, Lijun Huang^3*, Ruolan Zeng^3*, Yizi He^3*, Caiqin Wang^3*, Ling Xiao^4* and Hui Zhou, PhD¹

¹Hunan Cancer Hospital and Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
²Hunan Cancer Hospital, Changsha, China
³Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China
⁴Department of Histology and Embryology of School of Basic Medical Science, Central South University, Changsha, China

Haiwen Huang, M.D., PhD^1*, Mao Jin^2*, Caixia Li, MD^1*, Zhengming Jin, M.D.^1* and Depei Wu, MD, PhD^3,4

¹Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Department of Hematology, the First Affiliated Hospital of Soochow University, suzhou, China
³Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
⁴Department of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Suzhou, China

Leyla Bojanini, MD¹, Melba Herrera, MD^2*, Shufeng Li^3*, Tarek Bandali, MD^2*, Nicole Y. Xu^2*, Abdullah A. Ahmed^2*, Michael S. Khodadoust, MD, PhD⁴ and Youn H. Kim, MD⁴

¹Department of Medicine, Division of Hematology-Oncology, University of Texas Health-San Antonio, San Antonio, TX
²Department of Dermatology, Stanford University School of Medicine, Stanford, CA
³Stanford University School of Medicine, Department of Dermatology and Urology, Stanford, CA
⁴Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA

Li Yuxi, MD^1,2*, Rui Cui^1,3,4*, Ying Yu^1,5*, Yanshan Huang^3,6*, Jingwen Sun^1,7*, Yuting Yan, MD^1,5*, Tingyu Wang^1,5*, Xiong Wenjie, MD^1,2*, Rui Lyu, MD^1,2*, Qi Wang, MD^1,7*, Wei LIU^1,3*, Gang An^1,2*, Weiwei Sui, MD^1,7*, Yan Xu^1,8*, Wenyang Huang, MD^1,7*, Dehui Zou^1,2*, Fengkui Zhang^1,3*, Huijun Wang^1,8*, Zhi-jian Xiao^1,9*, Lu-Gui Qiu^1,2 and Shuhua Yi, MD^1,7*

¹Tianjin Institutes of Health Science, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China
⁴Department of hematology, Tianjin First center hospital, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶Tianjin Institutes of Health Science, Tianjin, China, Tianjin, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Rishabh Lohray, MD^1*, Lei Feng, MS^2*, Auris O Huen, MD, PharmD^3*, Iyanuoluwa Ogundipe^4*, Luis Malpica, MD^5*, Bouthaina S. Dabaja, MD^6*, Julia Dai, MD^3*, Jillian R. Gunther, MD, PhD^6*, Chitra Hosing, MD⁷, Roberto N. Miranda, MD^8*, L. Jeffrey Medeiros, MD⁸, Samer A. Srour, MD⁷, Jeremy Ramdial, MD⁷, Francisco Vega, MD, PhD⁸, Mansoor Noorani, MD^5*, Amy A. Ayers, MPH^5*, Penny Q. Fang^6*, Luis E. Fayad, MD⁵, Chelsea C. Pinnix, MD, PhD⁶, Madeleine Duvic, MD^3*, Jie Xu, MD PhD^8*, Christopher R. Flowers, MD, MS⁵, Susan Y. Wu^6*, Kunhwa Kim, MD, MPH^9*, Carlos P Torres-Cabala, MD^10*, Swaminathan P Iyer, MD^5* and Ranjit Nair, MD^5*

¹Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University Of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Anath Lionel, MD, PhD¹, Karmila Murphy, NP^2*, Amy A. Ayers, MPH^2*, Christopher R. Flowers, MD, MS², Keyur P. Patel, MBBS, PhD³, Courtney D. DiNardo, MD, MSc⁴, Francisco Vega, MD, PhD³ and Dai Chihara, MD, PhD²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Oakville, ON, Canada
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX

Filippo Bagnoli, MD^1,2*, Jacopo Calabrese De Feo^1,2*, Francesca Livia Letizia Ricci^1*, Jacopo Mariotti^1*, Barbara Sarina^1*, Monica Balzarotti^1*, Daniela Taurino^1*, Daniele Mannina^1*, Chiara De Philippis^1*, Daoud Rahal, MD^3*, Arturo Bonometti^2,3*, Massimo Magagnoli^1*, Rita Mazza^1*, Marcello Rodari^4*, Laura Giordano^5*, Stefania Bramanti^1*, Carmelo Carlo-Stella, MD^1,6 and Armando Santoro, MD^7,8*

¹Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Italy
²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
³Pathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
⁴Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
⁵Biostatistic Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
⁶Department of Biomedical Sciences, Humanitas University, Milan, Italy
⁷IRCCS Humanitas Research Hospital, Rozzano, Italy
⁸Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

Ayumi Fujimoto, MD¹, Kana Miyazaki, MD, PhD², Takeshi Maeda, MD, PhD^3*, Kimikazu Yakushijin, MD, PhD⁴, Wataru Munakata, MD, PhD^5*, Takahiro Fujino, MD, PhD^6*, Yasuo Ejima, MD, PhD^7*, Nobuhiro Hiramoto, MD^8*, Noriko Fukuhara, MD, PhD⁹, Jun Takizawa, MD, PhD^10*, Dai Maruyama, MD, PhD¹¹, Nobuko Kubota, MD, PhD^12*, Hideki Goto, MD, PhD^13*, Rika Sakai, MD, PhD^14*, Senzo Taguchi, MD, PhD^15*, Naoko Asano, MD, PhD¹⁶, Fumihiro Ishida, MD, PhD^17,18, Motoko Yamaguchi, MD, PhD¹⁹ and Ritsuro Suzuki, MD, PhD²⁰

¹Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Koto-Ku, TKY, Japan
²Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
³Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan
⁴Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
⁵Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁶Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
⁷Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan
⁸Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
⁹Department of Hematology, Tohoku University School of Medicine, Sendai, Japan
¹⁰Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan
¹¹Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
¹²Division of Hematology, Saitama Cancer Center, Saitama, Japan
¹³Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
¹⁴Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
¹⁵Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
¹⁶Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan
¹⁷Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan
¹⁸Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan
¹⁹Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan
²⁰Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan

Seok Jin Kim, MD, PhD¹, SangEun Yoon, MD, PhD^2*, Ji Hyun Lee, MD, PhD³, Jeong-Ok Lee, MD⁴, Seong Hyun Jeong, MD^5*, Sung-Nam Lim, MD^6*, Ho-Jin Shin, MD^7*, Duck Hwan Yang^8* and Won Seog Kim, MD^9*

¹Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
²Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
³Dong-A University College of Medicine, Busan, South Korea
⁴Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
⁵Department of Internal Medicine, Ajou University School of Medicine, Suwon, KOR
⁶Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South)
⁷Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
⁸Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
⁹Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)

Christina Poh, MD^1,2, Jenna M. Voutsinas, MPH^2*, Ivan Huang, PharmD^1,2*, Edus H. Warren, MD, PhD^1,2, Caitlin A. Crimp, MD^2,3*, Mazyar Shadman, MD, MPH^1,2, Ryan C. Lynch, MD^2,4, Brian G. Till, MD^1,2, Chaitra S. Ujjani, MD^1,2, Mengyang Di, MD, PhD^1,2, Vikram Raghunathan, MD^1,2*, Stephen D. Smith, MD^1,2, Qian Vicky Wu, PhD^2*, Michi M. Shinohara, MD^2,3* and Ajay K. Gopal, MD^1,2

¹Division of Hematology and Oncology, University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA
³Division of Dermatology, University of Washington, Seattle, WA
⁴University of Washington, Seattle, WA

Wenyu Shi^1*, Yi Miao, MD^2,3*, Jianyong Li, MD^3,4, Jing Zhang, MD^3,5*, Xuzhang Lu^3,6*, Bingzong Li, MD, PhD^3,7, Chunling Wang, PhD^8,9,10*, Yun Zhuang^3,11*, Yuqing Miao^12*, Haiwen Ni, MD, PhD^3,13*, Xiaoyan Xie^3,14*, Jingyan Xu, MD^3,15*, Yunping Zhang^3,16*, Min Zhao^3,17*, Min Xu, PhD^9,18*, Wanchuan Zhuang, MD^3,19*, Weiying Gu, PhD^3,20*, Guoqiang Lin^9,21*, Haiying Hua, MD^3,22*, Jianfeng Zhu^3,23*, Maozhong Xu^3,24*, Tao Jia^3,25*, Ping Liu, MD, PhD^26* and Lijia Zhai^3,27*

¹Department of Oncology/Hematology, Affiliated Hospital of Nantong University, Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nantong, Jiangsu, China
²Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
³Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China
⁴First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁵Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Tianjin, AL, China
⁶Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China
⁷Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
⁸Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai'an, China
⁹Jiangsu Cooperative Lymphoma Group (JCLG)., Nanjing, China
¹⁰Department of Hematology, Huai'an First People's Hospital, Huai'an, China
¹¹Department of Hematology, Wu Xi People's Hospital, Wuxi, China
¹²Department of Hematology, The First People’s Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, China
¹³The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, China
¹⁴Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China
¹⁵Department of Hematology, The Affliated Drum Tower Hospital, Nanjing, China
¹⁶The Affiliated Yixing Hospital of Jiangsu University, Yixing, China
¹⁷Department of Hematology, Wuhu Second People's Hospital, Wuhu, China
¹⁸Zhangjiagang First Affiliated Hospital of Soochow University, Zhangjiagang, China
¹⁹The Second People's Hospital of Lianyungang, Lianyungang, China
²⁰Department of Hematology, Changzhou First People's Hospital, Third Affiliated to Soochow University, Changzhou, China
²¹Department of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, China., Huai'an, China, China
²²Affiliated Hospital of Jiangnan University, Jiangsu, CHN
²³Department of Hematology, the People's Hospital of Taizhou, Taizhou, China
²⁴The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, China
²⁵The First People's Hospital of Lianyungang, Lianyungang, China
²⁶The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, CHN
²⁷Department of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China

Jie Chen^1*, Linjun Zhao^2*, Chongyang Wu^3*, Haifeng Yu^4*, Zhenling Li^5*, Lihong Liu^6*, Da Gao, MD^7*, Ying Sun^8*, Xiaolei Wei, MD^9*, Yuanbin Wu^10*, Yue Wang^1*, Yuqin Song, MD¹¹, Jun Zhu, PhD¹² and Weiping Liu^1*

¹Department of Lymphoma, Peking University Cancer Hospital, Beijing, China
²Department of Lymphoma, Peking University International Hospital, Beijing, China
³Lanzhou University Second Hospital, Lanzhou, China
⁴Department of Lymphatic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
⁵China-Japan Friendship Hospital, Beijing, China
⁶Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital, Shijiazhuang, China
⁷The affiliated hospital of inner mongolia medical univuniversity, Hohhot, China
⁸Department of Hematology, Chifeng Municipal Hospital, Chifeng, China
⁹Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
¹⁰Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China
¹¹Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
¹²Peking University Cancer Hospital, Beijing, China

Juan Esteban Garcia-Robledo, MD^1*, Henry Quintero, MD^2,3*, Denisse Castro, MD⁴, Brady E Beltran, MD^5,6*, Daniel J Enriquez, MD^7*, Jule F Vasquez, MD⁸, Claudia Roche, MD^9*, Daniel Artiles, MD^10*, Fabiola Valvert, MD, FRCP¹¹, Luis Mario Villela Martinez, MD, MSc^12*, Juliana Pereira, MD, PhD¹³, Ana Carolina Oliver, MD¹⁴, Jamila Vaz Tavarez, MD^15*, Sergio Augusto B Brasil, MD, PhD^16*, Karin Z Cecyn, MD^17*, Nelson S Castro, MD^18*, Renata Lyrio R Baptista, MD^19*, Samuel S. Medina, MD^20*, Davimar Miranda Maciel Borducchi, PhD²¹, Marcelo Bellesso, MD^22*, Danielle Leão Cordeiro De Farias, MD, MSc, MBA²³, Yung Gonzaga, MD^24*, Laura Korin, MD^25*, Patricio Pereyra, PhD^26*, Camila Peña, MD²⁷, Macarena Roa, MD^28*, Maria Alejandra Torres Viera, MD^29*, Kelly Meza, MD^30*, Seisha Von Glasenapp, PhD³¹, Alfredo Quiroz, MD^32*, Cesar Samanez-Figari, MD^33*, Rosa Oliday Rios Jimenez^34*, Sally Paredes, MD^4*, Thais Fischer, MD^35*, Asaad Trabolsi, MD³⁶, Jonathan H. Schatz, MD³⁷, Swaminathan P Iyer, MD^38*, Ranjit Nair, MD³⁹, Eduardo Edelman Saul, MD⁴⁰, Casey Bermack, MD³⁸, Jorge J. Castillo, MD⁴¹, Carmino De Souza, MD, PhD^42*, Eliana Miranda, PhD, MEd^42*, Bryan Valcarcel, MD, MPH⁴³, Carlos Chiattone, MD, PhD⁴⁴ and Luis Enrique Malpica Castillo, MD⁴⁵

¹Department of Hematology/Oncology, Instituto Oncológico Ospedale, Cali, Colombia
²Universidad Tecnológica de Pereira, Pereira, Colombia
³Clinica Central del Eje, Pereira, Colombia
⁴Hospital Edgardo Rebagliati Martins, Lima, Peru
⁵Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
⁶Instituto de Investigación en Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Peru
⁷Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru
⁸Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁹Hospital Armando Milan Castro, Vila Clara, Cuba
¹⁰Hospital Arnoldo Milan Castro, Vila Clara, Cuba
¹¹INCAN, Ciudad de Guatemala, Guatemala
¹²Hospital Fernando Ocaranza, Hermosillo, Mexico
¹³University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
¹⁴Bone marrow transplant unit, British Hospital, Montevideo, Uruguay
¹⁵Ophir Loyola Hospital, Belém, Brazil
¹⁶Hospital Santa Paula. São Paulo – Brazil, Sao Paulo, Brazil
¹⁷Federal University of Sao Paulo, Sao Paulo, Brazil
¹⁸Hospital de Cancer de Barretos, Barretos, São Paulo, BRA
¹⁹State University of Rio de Janeiro, Rio De Janeiro, Brazil
²⁰University of Campinas, São Paulo, BRA
²¹Medical School of ABC, Santo Andre, Brazil
²²HemoMed, Instituto de Ensino e Pesquisa – IEP, Sao Paulo, Brazil
²³Beneficencia Portuguesa Hospital, Sao Paulo, Brazil
²⁴Cancer National Institute, Rio De Janeiro, Brazil
²⁵CABA- Alexander Fleming Institute, Olivos, Argentina
²⁶Hospital Nacional Posadas, Buenos Aires, Argentina
²⁷Hospital Del Salvador, Santiago, Chile
²⁸Santiago Hospital del Salvador, Santiago, Chile
²⁹Clinica Santa Sofia, Caracas, Venezuela (Bolivarian Republic of)
³⁰Baylor College of Medicine, Houston, TX
³¹Hospital Central Instituto de Previsión Social, Asuncion, Paraguay
³²Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
³³Oncosalud, AUNA, Lima, Peru
³⁴Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
³⁵AC Camargo Cancer Center, Sao Paulo, AC, Brazil
³⁶University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
³⁷Department of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
³⁸University of Texas MD Anderson Cancer Center, Houston, TX
³⁹University of Texas MD Anderson Cancer Center, Pearland, TX
⁴⁰Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
⁴²Centro de Hematologia e Hemoterapia (HEMOCENTRO), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
⁴³Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Houston, TX
⁴⁴Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
⁴⁵Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Carlos Bravo-Perez, MD^1,2*, Carmelo Gurnari, MD, PhD^1,3, Arooj Ahmed^1*, Naomi Kawashima, MD PhD^1*, Zachary Brady^1*, Matteo D'Addona^1*, Luca Guarnera, MD^1*, Aashray Mandala, BS^1*, Kartik Lakhotiya, MS^1*, Christopher Haddad, BS^1*, Serhan Unlu, MD¹, Mark Orland, MD¹, Praveena Thiagarajan, MD, PhD^1*, Arda Durmaz, PhD^1*, Valeria Visconte, PhD¹ and Jaroslaw Maciejewski¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
³Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Kangjin Zhao^1* and Mingzhi Zhang, MD²

¹Zhengzhou University, Zhengzhou University, zhengzhou, China
²The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Pamela B. Allen, MD¹, Evan Bagley, PhD^2*, Kevin Graf, MD^3*, Tarsheen Sethi, MD, MSc⁴, Francine M. Foss, MD⁵, Ning Dong, MD MS⁶, Hayder Saeed, MD⁷, Jie Wang, MD, MS⁸, Christopher Dittus, DO, MPH⁹, Darina Paulino, MS^10*, Ryan A. Wilcox, MD, PhD¹¹, Stefan K. Barta, MD¹², Veronica Carvajal, BS^13*, Neha Mehta-Shah, MD¹⁴, Eric Mou, MD^15*, Aditya Ravindra, MD^16*, Bradley M. Haverkos, MD, MS, MPH¹⁷, Amitkumar N. Mehta, MD¹⁸, Lauren Kelly Shea, MD, MS¹⁸, Jasmine Zain, MD¹⁹, Daniel K Reef, MD²⁰, Ann Ayzman, MD^21* and Irl Brian Greenwell, MD²²

¹Winship Cancer Institute at Emory University, Decatur, GA
²Medical University of South Carolina, Charleston
³Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁴Hematology, Yale University School of Medicine, New Haven, CT
⁵Yale University School of Medicine, Hamden, CT
⁶H Lee Moffitt Cancer Center and Research Institute, Tampa
⁷Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁸Duke Cancer Institute, Hillsborough, NC
⁹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
¹⁰Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹¹Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
¹²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹³University of Pennsylvania, Philidelphia
¹⁴Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
¹⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹⁶Holden Comprehensive Cancer Center, University of Iowa Healthcare, Iowa City, IA
¹⁷University of Colorado Cancer Center, Aurora, CO
¹⁸O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
¹⁹City of Hope, Duarte, CA
²⁰Department of Medicine, Division of Oncology, University of North Carolina-Chapel Hill, Chapel Hill, NC
²¹Washington University in St. Louis, St. Louis, MO
²²Charleston Oncology, Charleston, SC

Chong Wei^1*, Shengyu Zhou^2*, Shuangnian Xu^3*, Hongmei Jing, MD⁴, Hui Liu^5*, Wei Zhang^1* and Daobin Zhou, MD^1*

¹Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
²Department of Hematology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
³Department of Hematology, Southwest Hospital, Third Military Medical University,(Army Medical University), Chongqing, China, Chongqing, China
⁴Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
⁵Department of Hematology, Beijing Hospital, Beijing, China

Thais Fischer, MD^1*, Eliana Miranda, PhD, MEd^2*, Juliana Pereira, MD, PhD³, Guilherme Duffles, MD^4*, Jamila Vaz Tavarez, MD^5*, Nelson S Castro, MD^6*, Rodrigo Santucci^7*, Danielle Leão Cordeiro De Farias, MD, MSc, MBA⁸, Sergio Brasil, MD^9*, Claudio G Macedo, MD^10*, Carolina Colaco, MD^11*, Renata Lyrio R Baptista, MD^12,13*, Karin Z Cecyn, MD^14*, Davimar Bortucchi, MD, PhD^15*, Gilnara Fontinele Silva, MD, MSc^16*, Samir Nabhan, MD^17*, Patricia Giacon, MD^18*, Rony Schaffel, MD, PhD¹⁹, Natalia Pin Chuen Zing, MD^20,21*, Frederico Lisboa Nogueira, MD²², Ademar Dantas Cunha, PhD²³, Diego Vila Cle^24*, Jose D Tadeu, MD^25*, Vera Figueiredo, MD^26*, Mateus Dalló Dal Pont, MD^27*, Rafael Gaiolla, MD, PhD^28*, Nelson Hamerschlak, MD, PhD²⁹, Eduardo Flavio Oliveira Ribeiro^30*, Abrahão Elias Hallack Neto, MD, PhD^31*, Maria Almeida Dias, MD^32*, Yung Gonzaga, MD^33*, Yana S Rabelo, MD^34*, Larissa Lane Teixeira, MD^35*, Guilherme Fleury Perini, MD^36,37, Milene Matedi, MD^38*, Priscilla Cury^39*, Henry Idrobo, MD^40*, Denisse Castro, MD⁴¹, Brady Beltran, MD^41*, Daniel J Enriquez, MD⁴², Jule F Vasquez, MD⁴³, Claudia Roche, MD^44*, Daniel Artiles, MD^45*, Fabiola Valvert, MD^46*, Luis Mario Villela Martinez^47*, Ana Carolina Oliver, MD⁴⁸, Laura Korin, MD^49*, Camila Peña, MD⁵⁰, Macarena Roa, MD^51*, Maria Alejandra Torres, MD^52*, Seisha Alana von Glasenapp, MD⁵³, Alfredo Quiroz, MD^54*, Cesar Samanez-Figari, MD^55*, Rosa Oliday Rios Jimenez^56*, Sally Paredes, MD^41*, Casey Bermack, MD⁵⁷, Kelly Meza, MD^58*, Bryan Valcarcel, MD, MPH⁵⁹, Carmino A Souza, MD^60*, Luis Malpica, MD^61* and Carlos Chiattone, MD, PhD⁶²

¹AC Camargo Cancer Center, Sao Paulo, AC, Brazil
²Centro de Hematologia e Hemoterapia (HEMOCENTRO), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
³University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
⁴Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
⁵Ophir Loyola Hospital, Belem, Brazil
⁶Hospital de Cancer de Barretos, Barretos, São Paulo, BRA
⁷HEMOMED, Sao Paulo, AM, BRA
⁸Beneficencia Portuguesa Hospital, Sao Paulo, Brazil
⁹Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
¹⁰CECAN, Natal, Brazil
¹¹Liga Contra o Cancer CECAN, Natal, Brazil
¹²Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Brazil
¹³State University of Rio de Janeiro, Rio De Janeiro, Brazil
¹⁴Federal University of Sao Paulo, Sao Paulo, Brazil
¹⁵ABC Medical School, Santo Andre, Brazil
¹⁶Aldenora Bello Hospital, Sao Luis, Brazil
¹⁷Federal University of Paraná, Parana, Brazil
¹⁸Santa Marcelina Hospital, Sao Paulo, Brazil
¹⁹HUCFF / UFRJ, Rio de Janeiro, Brazil
²⁰Prevent Senior, SAO PAULO, Brazil
²¹Hospital Beneficencia Portuguesa de SP, Sao Paulo, Brazil
²²Luxemburgo Hospital, Belo Horizonte, Brazil
²³Hospital do Cancer de Cascavel - UOPECCAN (Uniao Oeste Paranaense de Estudos e Combate ao Cancer), Cascavel, Brazil
²⁴USP Ribeirão, Ribeirao Preto, Brazil
²⁵FM Campos, Campos dos Goytacases, Brazil
²⁶Servidor Publico Estadual de Sao Paulo, Sao Paulo, Brazil
²⁷Centro de Pesquisas Oncologicas - CEPON, Santa Catarina, Brazil
²⁸Hospital Das Clínicas UNESP, Botucatu, Brazil
²⁹Departamento de Oncologia e Hematologia, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
³⁰Curitiba, Brazil; Department of Hematology, Santa Lucia Hospital - Brasilia, DF, Brazil, Brasilia, Brazil
³¹Juiz de Fora Federal University, Juiz de Fora, Brazil
³²Federal da Bahia Hospital, Salvador, Brazil
³³Cancer National Institute, Rio De Janeiro, Brazil
³⁴Goias Federal University, Goias, Brazil
³⁵Hospital Israelita Abert EInstein, São Paulo, BRA
³⁶Hospital Paulistano, São Paulo, Brazil
³⁷Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
³⁸Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
³⁹Clinica São Germano, São Paulo, Brazil
⁴⁰Universidad del Valle del Cauca, Cali, COL
⁴¹Hospital Edgardo Rebagliati Martins, Lima, Peru
⁴²Departamento de Oncologia Medica, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁴³Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁴⁴Hospital Armando Milan Castro, Vila Clara, Cuba
⁴⁵Hospital Arnoldo Milan Castro, Vila Clara, Cuba
⁴⁶INCAN, Mexico, Mexico
⁴⁷Mexico, Mexico, NM, MEX
⁴⁸Hospital Britanico de Montevideo, Montevideo, Uruguay
⁴⁹CABA- Alexander Fleming Institute, Olivos, Argentina
⁵⁰Hospital del Salvador, Santiago, Chile
⁵¹Hospital Del Salvador, Santiago, Chile
⁵²Santa Sofia Clinic, Caracas, Venezuela (Bolivarian Republic of)
⁵³Instituo de Previsión Social, Caracas, Venezuela (Bolivarian Republic of)
⁵⁴Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
⁵⁵San Borja, Lima, Peru
⁵⁶Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
⁵⁷University of Texas MD Anderson Cancer Center, Houston, TX
⁵⁸Baylor College of Medicine, Houston, TX
⁵⁹Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Houston, TX
⁶⁰University of Campinas, São Paulo, Brazil
⁶¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶²Santa Casa de São Paulo. São Paulo – Brazil, São Paulo, Brazil

Jia Ruan, MD, PhD¹, Evelyn H. Orlando, MD¹, Alison Moskowitz, MD², Zhengming Chen, PhD^3*, Neha Mehta-Shah, MD⁴, Lubomir Sokol, MD, PhD⁵, Steven Horwitz, MD², Sarah C. Rutherford, MD¹, Tejasvi Sahni^1*, Ari M Melnick, MD¹, Giorgio Inghirami, MD^6*, Leandro Cerchietti, MD¹, John P. Leonard, MD³ and Peter Martin, MD¹

¹Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Weill Cornell Medicine, New York, NY
⁴Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY